Review article: aspirin, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-1 sparing agents
Author:
- 26 August 2005
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics Symposium Series
- Vol. 1 (1) , 2-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The rise and decline of nonsteroidal antiinflammatory drug–associated gastropathy in rheumatoid arthritisArthritis & Rheumatism, 2004
- A coxib a day won't keep the doctor awayThe Lancet, 2004
- Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trialThe Lancet, 2004
- AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 UpdateCirculation, 2002
- Cyclooxygenase Inhibitors and the Antiplatelet Effects of AspirinNew England Journal of Medicine, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Risk of upper gastrointestinal bleeding associated with use of low-dose aspirinAmerican Journal of Gastroenterology, 2000
- Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory DrugsAnnals of Internal Medicine, 1995
- Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory DrugsAnnals of Internal Medicine, 1991